Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032675319> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W3032675319 endingPage "5" @default.
- W3032675319 startingPage "1" @default.
- W3032675319 abstract "ObjectiveTo investigate the influence of proline-rich tyrosine kinase 2 (Pyk2) gene RNA interference on proliferation, invasion and migration of Hep3B hepatocellular carcinoma cells.MethodsThe Pyk2 gene RNA interference vector was transfected in Hep3B hepatocellular carcinoma cells by lipofectamine. The Hep3B cells divided into three groups: siRNA group (the vector with Pyk2 RNAi gene was transfected), negative control group (the vector without Pyk2 RNAi gene was transfected), and blank control group (no vectors was transfected). Pyk2 mRNA and protein were detected using reverse transcription reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. The biological behavior including cell proliferation, invasion and migration were detected by 3-(4, 5-dimethyl-2-thiazoly)-2, 5-diphenyl-2H-tetrazolium bromide (MTT), transwell and wound healing assay, respectively.ResultsThe expression of Pyk2 mRNA of Hep3B cell line in siRNA group (0.16±0.03) was significantly decreased than those in negative group (0.74±0.13) and blank control group (0.77±0.16), with statistically significant differences (t=51.46, P=0.000; t=53.21, P=0.000). The expression of Pyk2 protein of Hep3B cell line in siRNA group (0.24±0.06) was significantly decreased than those in negative group (0.83±0.05) and blank control group (0.91±0.06), with statisti-cally significant differences (t=57.29, P=0.000; t=68.53, P=0.000). The cell proliferation inhibition rate at 48 hours in siRNA group (26.17%±0.28%) was significantly raised than those in negative group (9.28%±0.22%) and blank control group (6.47%±0.31%), with statistically significant differences (t=31.45, P=0.004; t=34.64, P=0.002). The number of transmembrane cells in siRNA group (32.5±8.5)/10 HP was significantly declined than those in negative group (98.4±12.3)/10 HP and blank control group (112.6±11.3)/10 HP, with statistically significant differences (t=95.64, P=0.000; t=105.17, P=0.000). The wound healing assay in siRNA group (28.17%±1.46%) was significantly lower than those in negative group (77.38%±2.24%) and blank control group (79.41%±3.17%), with statistically significant (t=85.86, P=0.000; t=89.37, P=0.000).ConclusionPyk2 gene involves the proliferation, invasion and migration of Hep3B cells, which has close correction with development and metastasis of hepatocellular carcinoma. Pyk2 gene is very helpful to become a molecular target for the diagnosis and treatment of hepatocellular carcinoma.Key words: Liver neoplasms; Cell proliferation; Neoplasm invasiveness; RNA interference; Proline-rich tyrosine kinase 2" @default.
- W3032675319 created "2020-06-05" @default.
- W3032675319 creator A5018904393 @default.
- W3032675319 creator A5035430754 @default.
- W3032675319 creator A5045048134 @default.
- W3032675319 creator A5057962192 @default.
- W3032675319 creator A5087765742 @default.
- W3032675319 creator A5091747832 @default.
- W3032675319 date "2017-01-08" @default.
- W3032675319 modified "2023-09-23" @default.
- W3032675319 title "Targeting Pyk2 gene on the proliferation, invasion and migration induction of hepatocelluar cancer Hep3B cells" @default.
- W3032675319 doi "https://doi.org/10.3760/cma.j.issn.1673-422x.2017.01.001" @default.
- W3032675319 hasPublicationYear "2017" @default.
- W3032675319 type Work @default.
- W3032675319 sameAs 3032675319 @default.
- W3032675319 citedByCount "0" @default.
- W3032675319 crossrefType "journal-article" @default.
- W3032675319 hasAuthorship W3032675319A5018904393 @default.
- W3032675319 hasAuthorship W3032675319A5035430754 @default.
- W3032675319 hasAuthorship W3032675319A5045048134 @default.
- W3032675319 hasAuthorship W3032675319A5057962192 @default.
- W3032675319 hasAuthorship W3032675319A5087765742 @default.
- W3032675319 hasAuthorship W3032675319A5091747832 @default.
- W3032675319 hasConcept C104317684 @default.
- W3032675319 hasConcept C105580179 @default.
- W3032675319 hasConcept C150194340 @default.
- W3032675319 hasConcept C153911025 @default.
- W3032675319 hasConcept C166703698 @default.
- W3032675319 hasConcept C22615655 @default.
- W3032675319 hasConcept C40767141 @default.
- W3032675319 hasConcept C4692481 @default.
- W3032675319 hasConcept C49923114 @default.
- W3032675319 hasConcept C54009773 @default.
- W3032675319 hasConcept C54355233 @default.
- W3032675319 hasConcept C55493867 @default.
- W3032675319 hasConcept C62112901 @default.
- W3032675319 hasConcept C67705224 @default.
- W3032675319 hasConcept C81885089 @default.
- W3032675319 hasConcept C86803240 @default.
- W3032675319 hasConcept C92087593 @default.
- W3032675319 hasConceptScore W3032675319C104317684 @default.
- W3032675319 hasConceptScore W3032675319C105580179 @default.
- W3032675319 hasConceptScore W3032675319C150194340 @default.
- W3032675319 hasConceptScore W3032675319C153911025 @default.
- W3032675319 hasConceptScore W3032675319C166703698 @default.
- W3032675319 hasConceptScore W3032675319C22615655 @default.
- W3032675319 hasConceptScore W3032675319C40767141 @default.
- W3032675319 hasConceptScore W3032675319C4692481 @default.
- W3032675319 hasConceptScore W3032675319C49923114 @default.
- W3032675319 hasConceptScore W3032675319C54009773 @default.
- W3032675319 hasConceptScore W3032675319C54355233 @default.
- W3032675319 hasConceptScore W3032675319C55493867 @default.
- W3032675319 hasConceptScore W3032675319C62112901 @default.
- W3032675319 hasConceptScore W3032675319C67705224 @default.
- W3032675319 hasConceptScore W3032675319C81885089 @default.
- W3032675319 hasConceptScore W3032675319C86803240 @default.
- W3032675319 hasConceptScore W3032675319C92087593 @default.
- W3032675319 hasIssue "1" @default.
- W3032675319 hasLocation W30326753191 @default.
- W3032675319 hasOpenAccess W3032675319 @default.
- W3032675319 hasPrimaryLocation W30326753191 @default.
- W3032675319 hasRelatedWork W150400339 @default.
- W3032675319 hasRelatedWork W2273578390 @default.
- W3032675319 hasRelatedWork W2358864928 @default.
- W3032675319 hasRelatedWork W2364357545 @default.
- W3032675319 hasRelatedWork W2365053151 @default.
- W3032675319 hasRelatedWork W2365886735 @default.
- W3032675319 hasRelatedWork W2380054069 @default.
- W3032675319 hasRelatedWork W2392800408 @default.
- W3032675319 hasRelatedWork W3029073629 @default.
- W3032675319 hasRelatedWork W3029570470 @default.
- W3032675319 hasRelatedWork W3030076200 @default.
- W3032675319 hasRelatedWork W3031346092 @default.
- W3032675319 hasRelatedWork W3031711274 @default.
- W3032675319 hasRelatedWork W3031998716 @default.
- W3032675319 hasRelatedWork W3032009398 @default.
- W3032675319 hasRelatedWork W3032036570 @default.
- W3032675319 hasRelatedWork W3032471356 @default.
- W3032675319 hasRelatedWork W3032635350 @default.
- W3032675319 hasRelatedWork W3032779392 @default.
- W3032675319 hasRelatedWork W3144618829 @default.
- W3032675319 hasVolume "44" @default.
- W3032675319 isParatext "false" @default.
- W3032675319 isRetracted "false" @default.
- W3032675319 magId "3032675319" @default.
- W3032675319 workType "article" @default.